Skip to main content
Edwards Lifesciences Logo

Comunicati stampa

newsroom banner image
October 05, 2026
Edwards Lifesciences to Host Investor Event in Conjunction With TCT
October 01, 2026
Edwards Lifesciences Receives FDA Approval for AUTUS Valve, the First Surgical Pulmonary Valve for Pediatric Patients
September 10, 2026
Edwards Lifesciences Comments on TAVR National Coverage Decision
September 02, 2026
Edwards Lifesciences to Present at the Deutsche Bank Healthcare Summit

Contatti

Investitori

Mark Wilterding
(SVP, Investor Relations)